IL17A and COVID-19: Since respiratory tract is the place of SRAS-CoV-2 entry and injury in COVID-19, we evaluated the expression level of IL-17 in gene expression data sets in nasopharyngeal swabs (GSE152075), and lung autopsies from large cohort of patients with COVID-19 (GSE150316).